# 바이오스페이스 일일 뉴스 리포트 - 2026년 02월 11일


## 주요 헤드라인

1. **Evommune Soars as Dermatitis Treatment Rivals Dupixent in Mid-Stage Trial (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/evommune-soars-as-dermatitis-treatment-rivals-dupixent-in-mid-stage-trial>

2. **Evommune Soars as Dermatitis Treatment Rivals Dupixent in Mid-Stage Trial (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/evommune-soars-as-dermatitis-treatment-rivals-dupixent-in-mid-stage-trial>

3. **Kailera, Hengrui Push Oral GLP-1/GIP Pill to Phase 3 After Clearing Mid-Stage China Study (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/kailera-hengrui-push-oral-glp-1-gip-pill-to-phase-3-after-clearing-mid-stage-china-study>

4. **Kailera, Hengrui Push Oral GLP-1/GIP Pill to Phase 3 After Clearing Mid-Stage China Study (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/kailera-hengrui-push-oral-glp-1-gip-pill-to-phase-3-after-clearing-mid-stage-china-study>

5. **AstraZeneca Teases ‘Very Competitive’ Weight-Loss Pill—But Stays Mum on Details (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/astrazeneca-teases-very-competitive-weight-loss-pill-but-stays-mum-on-details>

6. **HER2’s Digital Rebirth Is Unlocking the Full Potential of ADCs (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/her2s-digital-rebirth-is-unlocking-the-full-potential-of-adcs>

7. **Facing Talent Crunch, Radiopharma Field Casts a Wide Net (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/facing-talent-crunch-radiopharma-field-casts-a-wide-net>


---
*2026년 02월 11일 바이오스페이스 뉴스 피드에서 생성된 리포트*